Amyl Therapeutics

Liège, Belgium

Amyl Therapeutics is a preclinical stage biotechnology company.

$6.5M raised

Nov 2023

Grant

Biotechnology Health Care Life Science Medical

Top Investors

Mérieux Equity Partners Sambrinvest Smedvig Meusinvest (Noshaq)Evren Ucok

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Amyl Therapeutics

How much funding has Amyl Therapeutics raised?

Amyl Therapeutics has raised $6.5M in total funding. The most recent round was Grant. The last funding was announced in November 2023.

Who are Amyl Therapeutics's investors?

Amyl Therapeutics's investors include Mérieux Equity Partners, Sambrinvest, Smedvig, Meusinvest (Noshaq), Evren Ucok.

Where is Amyl Therapeutics headquartered?

Amyl Therapeutics is headquartered in Liège, Belgium.

What does Amyl Therapeutics do?

Amyl Therapeutics is a preclinical stage biotechnology company.

What stage is Amyl Therapeutics at?

Amyl Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 7, 2023.

MLA

"Amyl Therapeutics — Funding & Investors." VCBacked, November 7, 2023, https://www.vcbacked.co/company/amyl-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2023). Amyl Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/amyl-therapeutics

Wikipedia (cite web)

{{cite web |title=Amyl Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/amyl-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 7, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K